Personalized Weight‐Loss Targets for Metabolic Syndrome Reversal: A BMI ‐Normalization Achievement Rate‐Based Cohort Study
Authors' conclusion
MetS reversal does not require full BMI normalization. BMI-NAR provides a hypothesis-generating, quantifiable framework for exploring personalized minimum effective weight-loss goals in this high-risk population.
Study context
- Population
- Adults with overweight/obesity and metabolic syndrome (MetS), ChinaHEART project
- Participants
- 7,340 adults
- Exposure
- Per 50% increase in BMI-normalization achievement rate
- Outcome
- MetS reversal by BMI-NAR (% progress toward normal BMI <24 kg/m²)
Methodological detailsChinaHEART project
- ChinaHEART project
Main finding
As reported in the abstract
MetS reversal per 50% increase in BMI-NAR
Odds ratio (95% CI)
Overall
1.10(1.07–1.12)
Overweight
1.08(1.06–1.11)
Obesity
2.36(2.00–2.80)
Per 50% increase in BMI-NAR, as printed
Observational data: associations, not effects.
Further findings
Exploratory minimum effective BMI-normalization achievement rate (BMI-NAR) thresholds for MetS reversal
- Overall
- 37% BMI-NAR
- Overweight
- 53%
- Obesity
- 22%
- Benefits observed up to (total population)
- ≈165%
- No clear upper plateau in overweight and obesity
- Exploratory thresholds
Personalized minimum weight-loss targets
- Typical overweight (baseline BMI 25-27.99 kg/m²)
- 2%-8%
- Obesity
- 3%-9%
Original publication
Personalized Weight‐Loss Targets for Metabolic Syndrome Reversal: A BMI ‐Normalization Achievement Rate‐Based Cohort Study. Obesity (Silver Spring). Published 31 July 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →